Use of Virtual Reality in the Treatment of Flying Phobia
|ClinicalTrials.gov Identifier: NCT01442805|
Recruitment Status : Completed
First Posted : September 29, 2011
Last Update Posted : March 15, 2017
The project aims to explore the potential of Virtual Reality Exposure Therapy (VRET) for the treatment of the fear of driving, the fear of flying and the fear of public speaking.
The study is a randomized controlled trial (RCT) designed to compare the efficiency of cognitive behavioural therapy with exposures in imagination to behavioural therapy with exposures in virtual reality. Anxiety levels are measured using specific questionnaires, SUD ratings and physiological measures (heart rate, skin conductance, skin temperature, breathing frequency, heart rate variability).
Hypothesis: Treatments with exposures in virtual reality are more efficient than treatments with exposures in imagination.
|Condition or disease||Intervention/treatment|
|Flying Phobia||Behavioral: Virtual Reality Exposure Therapy Behavioral: Exposure Therapy through Imagination|
In the past, several studies have demonstrated the effectiveness of virtual reality exposure therapy in the treatment of flying phobia and driving phobia. As an objective tool, psychophysiological recordings help demonstrate the decrease of physiological aspects of anxiety reactions (heart rate, skin conductance, skin temperature, heart rate variability and breathing pattern).
The aim of the present study is to examine the effects of cognitive behavioural therapy with exposures in imagination to behavioural therapy with exposures in virtual reality in the treatment of patients with flying phobia. Thirty patients will be randomized into either an imagination exposure group or a virtual reality exposure group after having received four sessions of cognitive behavioural therapy for coping with panic attacks. Respective exposure therapies consist in four sessions.
Anxiety levels will be measured before and after the cognitive behavioural therapy for coping with panic attacks as well as before and after the exposure therapy sessions and after 3 months using specific questionnaires, SUD ratings and psychophysiological measures (heart rate, skin conductance, skin temperature, breathing frequency and heart rate variability). The exposure stimuli will consist in a 10min movie of a flight with an insight-cabin viewing perspective.
The investigators hypothesize that virtual reality exposure therapies will be more effective than imagination exposure therapy in terms of decrease of anxiety self-ratings and psychophysiological fear reactions.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||36 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Etude contrôlée Des Effets de la réalité Virtuelle Sur Les symptômes et Les paramètres Physiologiques de Certaines Phobies spécifiques|
|Study Start Date :||October 2008|
|Primary Completion Date :||September 2011|
|Study Completion Date :||March 2012|
Cognitive Behavioral Therapy with Virtual Reality Exposures
Behavioral: Virtual Reality Exposure Therapy
Participants are exposed to the feared situation (flying) through the virtual reality technology
Cognitive Behavioral Therapy with Exposure Therapy through Imagination
Behavioral: Exposure Therapy through Imagination
Participants are exposed to the feared situation (flying) through exposure technique of imagination.
- Flight taken [ Time Frame: 6 months ]Participants are expected to take a real flight
- Physiological Measures [ Time Frame: 6 months ]Heart Rate, Breathing frequency, Skin conductance, Skin Temperature, Heart Rate Variability
- Specific Questionnaires [ Time Frame: 6 months ]Specific Questionnaires: SUD, Motivational Scale, Fear Questionnaire Marks 1979, Sheehan Disability Scale, STAI I & II, BDI, BAI, GAF, Flight Anxiety Situations Questionnaire FAS, Flight Anxiety Modality Questionnaire FAM
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01442805
|Centre de Recherche Public de la Santé|
|Strassen, Luxembourg, L-1445|
|Principal Investigator:||Charles Pull, Prof.Dr.||Centre de Recherche Public de la Santé|